1. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy

   • Luyuan Li
   • Josiane E. Eid
   • Jonathan C. Trent

   Leading Article 24 August 2017 Pages: 379 - 392

   

2. Asthma Phenotypes and Endotypes: Implications for Personalised Therapy

   • Katrina Dean
   • Robert Niven

   Leading Article 06 September 2017 Pages: 393 - 408

   

3. Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential

   • Paras P. Vakharia
   • Jonathan I. Silverberg

   Review Article 29 August 2017 Pages: 409 - 422

   

4. Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease

   • Paul Lawrence
   • Joseph Ceccoli

   Review Article Open access 05 September 2017 Pages: 423 - 438

   

5. Patients’ Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey

   • Mohammed I. Aladul
   • Raymond W. Fitzpatrick
   • Stephen R. Chapman

   Original Research Article 27 July 2017 Pages: 439 - 446

   

6. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists

   • Eline van Overbeeke
   • Birgit De Beleyr
   • Isabelle Huys

   Original Research Article 19 September 2017 Pages: 447 - 459

   

7. SB2: An Infliximab Biosimilar

   • Yvette N. Lamb
   • Lesley J. Scott
   • Emma D. Deeks

   Adis Biosimilar Brief 12 August 2017 Pages: 461 - 464

   

8. GP2013: A Rituximab Biosimilar

   • Hannah A. Blair

   Adis Biosimilar Brief 18 September 2017 Pages: 465 - 468